Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.43 | N/A |
| PEG Ratio (TTM) | -5.46 | N/A |
| P/S Ratio (TTM) | 1.60 | N/A |
| P/B Ratio (TTM) | 0.93 | N/A |
| P/FCF Ratio (TTM) | 12.56 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.69 | N/A |
| Price to 5YR AVG FCF Ratio | 7.56 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.48% | N/A |
| ROE (TTM) | 5.48% | N/A |
| Net Profit Margin (TTM) | 9.20% | N/A |
| ROIC 5YR AVG | 12.47% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.97% | 26.21% | 16.30% |
| Revenue | 8.20% | 9.69% | 6.65% |
| Net Income | -3.35% | 26.26% | 15.14% |
| Cash Flow | 1,055.17% | 27.46% | 19.78% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 15.66 | N/A |
| Quick Ratio (TTM) | 15.66 | N/A |
| D/E Ratio (TTM) | 0.22 | N/A |
| Interest Coverage (TTM) | 0.88 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 1.95 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.19% | N/A |